Repulsive guidance molecules, novel bone morphogenetic protein co-receptors, are key regulators of the growth and aggressiveness of prostate cancer cells

International Journal of Oncology

Volumn 40, Issue 2, 2012, Pages 544-550

  Li, Jin ^a   Ye, Lin ^a   Kynaston, Howard G ^a   Jiang, Wen G ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Bone morphogenetic protein; ID1; Prostate cancer; Repulsive guidance molecule; Smad

Indexed keywords

BONE MORPHOGENETIC PROTEIN RECEPTOR; HEMOJUVELIN; MEMBRANE PROTEIN; OSTEOGENIC PROTEIN 1; PROTEIN ANTIBODY; REPULSIVE GUIDANCE MOLECULE DOMAIN FAMILY MEMBER A; REPULSIVE GUIDANCE MOLECULE DOMAIN FAMILY MEMBER B; SMAD1 PROTEIN; SMAD3 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER GROWTH; CELL ADHESION; CELL GROWTH; CELL INVASION; CELL LINE; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; GENE SILENCING; GROWTH REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

BONE MORPHOGENETIC PROTEIN RECEPTORS; CELL ADHESION; CELL ADHESION MOLECULES, NEURONAL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; GPI-LINKED PROTEINS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 1; MALE; MEMBRANE PROTEINS; NEOPLASM INVASIVENESS; NERVE TISSUE PROTEINS; PHOSPHORYLATION; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; SMAD1 PROTEIN; SMAD3 PROTEIN;

EID: 84862973218     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1251     Document Type: Article

References (29)

1. Ye L, Mason MD and Jiang WG: Bone morphogenetic protein and bone metastasis, implication and therapeutic potential. Front Biosci 16: 865-897, 2011.
2. Babitt JL, Zhang Y, Samad TA, et al: Repulsive guidance molecule (RGMa), a DRAGON homologue, is a bone morphogenetic protein co-receptor. J Biol Chem 280: 29820-29827, 2005. (Pubitemid 41177060)
3. Papanikolaou G, Samuels ME, Ludwig EH, et al: Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 36: 77-82, 2004. (Pubitemid 38056211)
4. Monnier PP, Sierra A, Macchi P, et al: RGM is a repulsive guidance molecule for retinal axons. Nature 419: 392-395, 2002.
5. Liu X, Hashimoto M, Horii H, et al: Repulsive guidance molecule b inhibits neurite growth and is increased after spinal cord injury. Biochem Biophys Res Commun 382: 795-800, 2009.
6. Samad TA, Rebbapragada A, Bell E, et al: DRAGON, a bone morphogenetic protein co-receptor. J Biol Chem 280: 14122-14129, 2005. (Pubitemid 40517314)
7. Xia Y, Yu PB, Sidis Y, et al: Repulsive guidance molecule RGMa alters utilization of bone morphogenetic protein (BMP) type II receptors by BMP2 and BMP4. J Biol Chem 282: 18129-18140, 2007. (Pubitemid 47100254)
8. Babitt JL, Huang FW, Wrighting DM, et al: Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet 38: 531-539, 2006.
9. Xia Y, Cortez-Retamozo V, Niederkofler V, et al: Dragon (repulsive guidance molecule B) inhibits IL-6 expression in macrophages. J Immunol 186: 1369-1376, 2010.
10. Conrad S, Genth H, Hofmann F, et al: Neogenin-RGMa signaling at the growth cone is bone morphogenetic protein-independent and involves RhoA, ROCK, and PKC. J Biol Chem 282: 16423-16433, 2007. (Pubitemid 47100392)
11. Kanomata K, Kokabu S, Nojima J, et al: DRAGON, a GPI-anchored membrane protein, inhibits BMP signaling in C2C12 myoblasts. Genes Cells 14: 695-702, 2009.
12. Lee DH, Zhou LJ, Zhou Z, et al: Neogenin inhibits HJV secretion and regulates BMP-induced hepcidin expression and iron homeostasis. Blood 115: 3136-3145, 2010.
13. Miyazaki H, Watabe T, Kitamura T, et al: BMP signals inhibit proliferation and in vivo tumor growth of androgen-insensitive prostate carcinoma cells. Oncogene 23: 9326-9335, 2004. (Pubitemid 40069665)
14. Ye L, Kynaston H and Jiang WG: Bone morphogenetic protein-9 induces apoptosis in prostate cancer cells, the role of prostate apoptosis response-4. Mol Cancer Res 6: 1594-1606, 2008.
15. Ye L, Kynaston H and Jiang WG: Bone morphogenetic protein-10 suppresses the growth and aggressiveness of prostate cancer cells through a Smad independent pathway. J Urol 181: 2749-2759, 2009.
16. Li VS, Yuen ST, Chan TL, et al: Frequent inactivation of axon guidance molecule RGMA in human colon cancer through genetic and epigenetic mechanisms. Gastroenterology 137: 176-187, 2009.
17. Jiang WG, Grimshaw D, Martin TA, et al: Reduction of stromal fibroblast-induced mammary tumor growth, by retroviral ribozyme transgenes to hepatocyte growth factor/scatter factor and its receptor, c-MET. Clin Cancer Res 9: 4274-4281, 2003. (Pubitemid 37204049)
18. Jiang WG, Davies G, Martin TA, et al: Targeting matrilysin and its impact on tumor growth in vivo: the potential implications in breast cancer therapy. Clin Cancer Res 11: 6012-6019, 2005. (Pubitemid 41170333)
19. Parr C, Watkins G and Jiang WG: The possible correlation of Notch-1 and Notch-2 with clinical outcome and tumour clinicopathological parameters in human breast cancer. Int J Mol Med 14: 779-786, 2004.
20. Norton JD: ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J Cell Sci 113: 3897-3905, 2000.
21. Forootan SS, Wong YC, Dodson A, et al: Increased Id-1 expression is significantly associated with poor survival of patients with prostate cancer. Hum Pathol 38: 1321-1329, 2007. (Pubitemid 47247487)
22. Miyazono K and Miyazawa K: ID: a target of BMP signaling. Sci STKE, 2002: pe40, 2002.
23. Valdimarsdottir G, Goumans MJ, Rosendahl A, et al: Stimulation of Id1 expression by bone morphogenetic protein is sufficient and necessary for bone morphogenetic protein-induced activation of endothelial cells. Circulation 106: 2263-2270, 2002. (Pubitemid 35222223)
24. Yap WN, Chang PN, Han HY, et al: Gamma-tocotrienol suppresses prostate cancer cell proliferation and invasion through multiple-signalling pathways. Br J Cancer 99: 1832-1841, 2008.
25. Yap WN, Zaiden N, Tan YL, et al: Id1, inhibitor of differentiation, is a key protein mediating anti-tumor responses of gamma-tocotrienol in breast cancer cells. Cancer Lett 291: 187-199, 2010.
26. Ying QL, Nichols J, Chambers I, et al: BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115: 281-292, 2003. (Pubitemid 37487702)
27. Belletti B, Prisco M, Morrione A, et al: Regulation of Id2 gene expression by the insulin-like growth factor I receptor requires signaling by phosphatidylinositol 3-kinase. J Biol Chem 276: 13867-13874, 2001.
28. Lasorella A, Noseda M, Beyna M, et al: Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins. Nature 407: 592-598, 2000.
29. Ohtani N, Zebedee Z, Huot TJ, et al: Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature 409: 1067-1070, 2001. (Pubitemid 32204062)